Cargando…
Toward wide-spectrum antivirals against coronaviruses: Molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors
To date, effective therapeutic treatments that confer strong attenuation against coronaviruses (CoVs) remain elusive. Among potential drug targets, the helicase of CoVs is attractive due to its sequence conservation and indispensability. We rely on atomistic molecular dynamics simulations to explore...
Autores principales: | Perez-Lemus, Gustavo R., Menéndez, Cintia A., Alvarado, Walter, Byléhn, Fabian, de Pablo, Juan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741187/ https://www.ncbi.nlm.nih.gov/pubmed/34995115 http://dx.doi.org/10.1126/sciadv.abj4526 |
Ejemplares similares
-
Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease
por: Menéndez, Cintia A., et al.
Publicado: (2020) -
Modeling the Binding Mechanism of Remdesivir, Favilavir,
and Ribavirin to SARS-CoV-2 RNA-Dependent RNA Polymerase
por: Byléhn, Fabian, et al.
Publicado: (2021) -
DExD/H-box helicase 9 intrinsically controls CD8(+) T cell–mediated antiviral response through noncanonical mechanisms
por: Jiao, Anjun, et al.
Publicado: (2022) -
The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex with its viral partner nsp3a
por: Bessa, Luiza Mamigonian, et al.
Publicado: (2022) -
Genome-wide screening identifies Polycomb repressive complex 1.3 as an essential regulator of human naïve pluripotent cell reprogramming
por: Collier, Amanda J., et al.
Publicado: (2022)